Adalimumab and sulfasalazine in alleviating sacroiliac and aortic inflammation detected in PET/CT in patients with axial spondyloarthritis: PETSPA.

Immun Inflamm Dis · 2022 · PMC8767522 · PMID 34755937

Europe PMC DOI

hedged sentences

0.0870

closest p · 1.7× alpha

0.0870

boldest claim

The sentences

a decreasing trendp = .087so close (0.05 < p ≤ 0.1)

Among the SSZ group, the SUVmax in the SI joints declined markedly from 2.35 ± 0.55 to 1.51 ± 0.22 (−35.8%, p = .022), with a decreasing trend for aortic TBRmax from 1.59 ± 0.46 to 1.26 ± 0.43 (−33.2%, p = .087).

also in 47,180 other papers

did not reach statistical significanceno p-value reported

18 In our study, ADA and SSZ both seemed to reduce clinical symptoms, even though SSZ did not reach statistical significance, probably due to the small number of patients.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.